vs

Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and Verisign (VRSN). Click either name above to swap in a different company.

Verisign is the larger business by last-quarter revenue ($425.3M vs $382.2M, roughly 1.1× LifeStance Health Group, Inc.). Verisign runs the higher net margin — 48.5% vs 3.1%, a 45.4% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 7.6%). Verisign produced more free cash flow last quarter ($285.1M vs $46.6M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 5.2%).

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.

LFST vs VRSN — Head-to-Head

Bigger by revenue
VRSN
VRSN
1.1× larger
VRSN
$425.3M
$382.2M
LFST
Growing faster (revenue YoY)
LFST
LFST
+9.9% gap
LFST
17.4%
7.6%
VRSN
Higher net margin
VRSN
VRSN
45.4% more per $
VRSN
48.5%
3.1%
LFST
More free cash flow
VRSN
VRSN
$238.5M more FCF
VRSN
$285.1M
$46.6M
LFST
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
5.2%
VRSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LFST
LFST
VRSN
VRSN
Revenue
$382.2M
$425.3M
Net Profit
$11.7M
$206.2M
Gross Margin
88.5%
Operating Margin
4.7%
67.0%
Net Margin
3.1%
48.5%
Revenue YoY
17.4%
7.6%
Net Profit YoY
264.1%
7.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFST
LFST
VRSN
VRSN
Q4 25
$382.2M
$425.3M
Q3 25
$363.8M
$419.1M
Q2 25
$345.3M
$409.9M
Q1 25
$333.0M
$402.3M
Q4 24
$325.5M
$395.4M
Q3 24
$312.7M
$390.6M
Q2 24
$312.3M
$387.1M
Q1 24
$300.4M
$384.3M
Net Profit
LFST
LFST
VRSN
VRSN
Q4 25
$11.7M
$206.2M
Q3 25
$1.1M
$212.8M
Q2 25
$-3.8M
$207.4M
Q1 25
$709.0K
$199.3M
Q4 24
$-7.1M
$191.5M
Q3 24
$-6.0M
$201.3M
Q2 24
$-23.3M
$198.8M
Q1 24
$-21.1M
$194.1M
Gross Margin
LFST
LFST
VRSN
VRSN
Q4 25
88.5%
Q3 25
88.4%
Q2 25
88.0%
Q1 25
87.7%
Q4 24
87.8%
Q3 24
88.0%
Q2 24
87.8%
Q1 24
87.2%
Operating Margin
LFST
LFST
VRSN
VRSN
Q4 25
4.7%
67.0%
Q3 25
2.0%
67.8%
Q2 25
-0.9%
68.5%
Q1 25
0.5%
67.4%
Q4 24
0.3%
66.7%
Q3 24
0.0%
68.9%
Q2 24
-5.1%
68.8%
Q1 24
-5.6%
67.4%
Net Margin
LFST
LFST
VRSN
VRSN
Q4 25
3.1%
48.5%
Q3 25
0.3%
50.8%
Q2 25
-1.1%
50.6%
Q1 25
0.2%
49.5%
Q4 24
-2.2%
48.4%
Q3 24
-1.9%
51.5%
Q2 24
-7.5%
51.4%
Q1 24
-7.0%
50.5%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFST
LFST
VRSN
VRSN
Cash + ST InvestmentsLiquidity on hand
$248.6M
$580.5M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$1.5B
$-2.2B
Total Assets
$2.2B
$1.3B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFST
LFST
VRSN
VRSN
Q4 25
$248.6M
$580.5M
Q3 25
$203.9M
$617.7M
Q2 25
$188.9M
$593.8M
Q1 25
$134.3M
$648.5M
Q4 24
$154.6M
$599.9M
Q3 24
$102.6M
$644.9M
Q2 24
$87.0M
$689.9M
Q1 24
$49.5M
$924.7M
Total Debt
LFST
LFST
VRSN
VRSN
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
LFST
LFST
VRSN
VRSN
Q4 25
$1.5B
$-2.2B
Q3 25
$1.5B
$-2.1B
Q2 25
$1.5B
$-2.0B
Q1 25
$1.5B
$-2.0B
Q4 24
$1.4B
$-2.0B
Q3 24
$1.4B
$-1.9B
Q2 24
$1.4B
$-1.8B
Q1 24
$1.4B
$-1.6B
Total Assets
LFST
LFST
VRSN
VRSN
Q4 25
$2.2B
$1.3B
Q3 25
$2.1B
$1.4B
Q2 25
$2.1B
$1.4B
Q1 25
$2.1B
$1.4B
Q4 24
$2.1B
$1.4B
Q3 24
$2.1B
$1.5B
Q2 24
$2.1B
$1.5B
Q1 24
$2.1B
$1.7B
Debt / Equity
LFST
LFST
VRSN
VRSN
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFST
LFST
VRSN
VRSN
Operating Cash FlowLast quarter
$57.6M
$289.6M
Free Cash FlowOCF − Capex
$46.6M
$285.1M
FCF MarginFCF / Revenue
12.2%
67.0%
Capex IntensityCapex / Revenue
2.9%
1.1%
Cash ConversionOCF / Net Profit
4.93×
1.40×
TTM Free Cash FlowTrailing 4 quarters
$110.0M
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFST
LFST
VRSN
VRSN
Q4 25
$57.6M
$289.6M
Q3 25
$27.3M
$307.7M
Q2 25
$64.4M
$202.5M
Q1 25
$-3.1M
$291.3M
Q4 24
$62.3M
$231.5M
Q3 24
$22.7M
$253.4M
Q2 24
$44.1M
$160.4M
Q1 24
$-21.8M
$257.3M
Free Cash Flow
LFST
LFST
VRSN
VRSN
Q4 25
$46.6M
$285.1M
Q3 25
$17.0M
$303.0M
Q2 25
$56.6M
$194.7M
Q1 25
$-10.3M
$285.5M
Q4 24
$56.0M
$222.0M
Q3 24
$17.7M
$247.8M
Q2 24
$39.0M
$151.2M
Q1 24
$-26.9M
$253.5M
FCF Margin
LFST
LFST
VRSN
VRSN
Q4 25
12.2%
67.0%
Q3 25
4.7%
72.3%
Q2 25
16.4%
47.5%
Q1 25
-3.1%
71.0%
Q4 24
17.2%
56.1%
Q3 24
5.7%
63.4%
Q2 24
12.5%
39.1%
Q1 24
-9.0%
66.0%
Capex Intensity
LFST
LFST
VRSN
VRSN
Q4 25
2.9%
1.1%
Q3 25
2.8%
1.1%
Q2 25
2.2%
1.9%
Q1 25
2.2%
1.4%
Q4 24
1.9%
2.4%
Q3 24
1.6%
1.4%
Q2 24
1.6%
2.4%
Q1 24
1.7%
1.0%
Cash Conversion
LFST
LFST
VRSN
VRSN
Q4 25
4.93×
1.40×
Q3 25
25.34×
1.45×
Q2 25
0.98×
Q1 25
-4.36×
1.46×
Q4 24
1.21×
Q3 24
1.26×
Q2 24
0.81×
Q1 24
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons